Journal of Virological Methods, 12 (1985) 193-198
193
Elsevier JVM 00449
RADIOIMMUNOASSAY PARVOVIRUS
OF ADJUVANT-ASSOCIATED
USING A MONOCLONAL
NITROCELLULOSE
JONATHAN
MEMBRANE
B. KATZ
and RICHARD
PORCINE
ANTIBODY
IN A
SYSTEM
A. VAN DEUSEN
Biologics Virology Laboratory, National Veterinary Services Laboratories, Veterinary Services, Animal and Planr Health Inspection Service, U.S. Department of Agriculture, P.O. Box 844, Ames, IA 50010, U.S.A. (Accepted
6 August
A quantitative
1985)
and simple
indirect
radioimmunoassay
(PPV), employing
a monoclonal
IRIA was equally
sensitive to live or inactivated
bound
radioactivity
commercially radioactivity
and PPV quantity
used adjuvants,
directed
were prepared
between
in adjuvants
of 16 commercial
vitro estimation
according
radioimmunoassay
hydroxide
bound
At fixed adjuvant
radioactivity
to commercial
parvovirus
for porcine
to nitrocellulose
(AH) and carboxyvinyl
manner.
mass in adjuvanted
porcine
was developed
PPV adsorbed
PPV. There was a linear relationship
parvovirus
membrane.
The
between membrane-
(HA) units of virus. Two
polymer
(CP), reduced
concentrations,
bound
there were, never-
and HA units of PPV. Known
vaccine formulations.
PPV vaccines was estimated
of antigenic
(IRIA)
against
within a range of IO-83 hemagglutinating
aluminum
in a concentration-dependent
theless, linear relationships content
antibody
amounts
Using these standards,
by IRIA. The IRIA may be one practical
of PPV the PPV
method of in
vaccines.
adjuvanted
vaccines
INTRODUCTION
Potency expensive, procedures
evaluation procedures
of adjuvanted vaccines customarily requiring host animals or laboratory
may include
challenge
protection,
or assays
involves lengthy, animal surrogates. for antibodies
often These
by plaque
reduction, indirect fluorescent antibody, hemagglutination inhibition, orenzyme-linked immunosorbent assay methods. Although there is currently no in vitro method for the complete assessment of adjuvanted vaccine efficacy, protein immunoassay techniques have enabled direct measurement of selected antigens (Hawkes et al., 1982; Furuya et al., 1984; Porter and Porter, 1984). The ability of nitrocellulose to bind biological macromolecules, as noted by Tsuchida et al. (1973), has been utilized by Southern (1975) and others (Hawkes et al., 1982; Flores et al., 1983) for rapid immobilization of the antigen to be measured. Kostenbader and Cliver (1983) demonstrated that viral adsorption to nitrocellulose could be quantitative. With the availability of an anti-porcine parvovirus (PPV) monoclonal antibody, it was of interest to 0166-0934/85/$03.30
0 1985 Elsevier Science Publishers
B.V. (Biomedical
Division)
194
determine
if complex,
radioimmunoassay. nal antibody
adjuvanted
PPV vaccines could be evaluated
The assay described
directed
against
lose. Bound monoclonal
PPV present
antibody
for viral content
below employs an anti-PPV in vaccine specimens
by
mouse monoclo-
dotted on nitrocellu-
is then detected using 1251-labelled sheep anti-mouse
immunoglobulin. MATERIALS
AND
METHODS
Reference virus PPV virus (NADL-8 Services Laboratories, embryonic
swine kidney
strain, Diagnostic Virology Ames, IA) was expanded cells. Virus was concentrated
Laboratory, National in a rapidly growing in semipurified
Veterinary culture of
form through
brief sonication of infected cells, pH elevation to 8.6, and differential centrifugation by the method of Dr.W. Mengeling (1985, National Animal Disease Center, Ames, IA; pers. comm.). The resulting material had 4,000 hemagglutination (HA) units per 50 pl and was frozen at -80°C until use. One HA unit was defined as the minimum quantity of virus per 50 ul which produced complete agglutination when added to an equal volume of 0.5% (v/v) guinea pig red blood cells suspended in 0.01 M phosphate buffered saline (PBS), pH 7.4. Formalin-inactivated and binary ethyleneimine-(BEI) inactivated testing.
PPV were also stored similarly
to await indirect
radioimmunoassay
(IRIA)
Anti-PPV monoclonal antibody Several hybridoma cell lines producing monoclonal anti-PPV antibodies were obtained (Mengeling et al., 1984) recloned, and expanded to produce ascites in BALB/c mice using standard procedures (Van Deusen and Whetstone, 1981). Ascites from clone 3C9Dll (MAB) had a PPV hemagglutination-inhibition titer of 256, and was functional in IRIA. Optimal signal-to-background ratios were achieved at a 1 : 50 dilution of MAB in blocking solution. Blocking solution in this and all subsequent steps consisted of 5% (w/v) generic non-fat dry milk and 0.02% (w/v) sodium azide in PBS. 1251-labelled second antibody *251-labelled sheep anti-mouse Corporation, Arlington Heights, dilution minimal
immunoglobulin was purchased from Amersham IL, and used within 4 wk of production. A 1 : 300
of isotopic second antibody background.
in blocking
solution
yielded optimal
signal with
Adjuvants and formulations of adjuvant-associated virus preparations Aluminum hydroxide (AH), carboxyvinyl polymer (CP), and a pyran copolymer (AA) were obtained either from firms producing USDA-licensed inactivated PPV vaccines or from Dr. R. Levings, Biologics Virology Laboratory, NVSL, Ames, IA.
195
Formulations
resembling
proprietary
except that known amounts ul final mixture)
adjuvanted
PPV vaccines
of PPV reference virus (80,60,40,20,
were added to form standards
ence AH and CP, supplied
for IRIA testing.
known
contained
concentrations
were prepared
gel in EMEM-FBS.
referin
(v/v). Each of these
40 HA units of PPV per 10 ul final product.
Finally,
a series of
of PPV (80, 60, 40, 20, 10, 0 HA units per 10 ul final mixture)
in each of 4 media: 0.01 M PBS, Eagle’s Minimal
5% (v/v) fetal bovine
Additionally,
as 3% (w/v) and 10% (w/v) gels in water, were prepared
0.01 M PBS at 20%, 15%, lo%, 5%, 2.5% and 0% concentrations references
were constructed, 10,O HA units per 10
serum (EMEM-FBS), The FBS was tested
antibody
at a 1 : 2 dilution
different
media provided
against
IRIA technique Nitrocellulose membranes
and found
100 TCID,,
additional
references
(Biorad
Essential
Medium with
10% AH gel in EMEM-FBS, negative
and 5% CP
for neutralizing
of PPV. These dilutions
PPV
of PPV in
for IRIA evaluation.
Laboratories,
Richmond,
CA) were rinsed in
deionized water, dried, and sliced into 1 cm* squares. Then ul aliquots of the test material were dotted onto the squares, dried, and the squares placed individually in wells of a 24-well disposable
tissue culture
plate. One ml of blocking
solution
was
added per well for 1 h. This and all other reactions were at room temperature and were conducted with gentle rotary mixing on an orbital shaker. Following aspiration of blocker, 250 ul of MAB diluted in blocker was added per well and incubated 90 min followed by four lo-min washes with 1 ml blocker per well. Then 250 ul of L251-sheep anti-mouse immunoglobulin in blocker was added per well. After 90 min this reagent was aspirated, followed by four IO-min washes with blocker as before. Each square was then removed and counted in a Packard Multi-Prias gamma counter (Downers Grove, IL) for 10 min. RESULTS
The IRIA was used to measure from 0.8 HA units up to 800 HA units of PPV applied to nitrocellulose measured,
squares.
However,
and the IRIA exhibited
for routine
use, a range of lo-80
a linear relationship
between
bound
HA units was radioactivity
and HA units of virus within these limits (Fig. 1). Live, formalin-inactivated, and BEI-inactivated virus preparations were equally well recognized. Reference suspensions of high-titered pseudorabies virus grown in swine kidney cells went unrecognized by this MAB-specific system, as did high-titered reference suspensions of transmissible gastroenteritis virus grown in swine testicle cells (both viruses supplied by Biologics Virology Laboratory, NVSL, Ames, IA). This information indicated that the assay was insensitive to typical swine host cell antigens and nutrient serum proteins which might be commonly ture.
employed
in producing
virus-laden
As shown in Fig. 2, AH gel and CP gel both significantly
fluids for vaccine
manufac-
(P< 0.05) depressed
IRIA
196
0;
0
,
,
,
,
,
,
,
IO
20
30
40
50
60
70
, 80 ADJUVANTPERCENTAGE &GEL INOOIMPBSI
HA UNITS OF PPV
Fig. 1. Titration
of PPV in 0.01 M PBS by IRIA.
Fig. 2. Effect of adjuvant duplicate
measurements
percentages
level on IRIA (background
of AH gel (o---o)
sensitivity
Each point is a mean of triplicate
measurement
subtracted)
of 40 HA units of PPV. All points
are means
of 40 HA units of virus in the presence
of
of variable
or CP gel (o-o).
to PPV in a concentration
dependent
manner,
but did not significantly
elevate background or eliminate the linearity of the recognition given adjuvant concentration tested (Fig. 3). Figure 4 presents
measurements
titrations
of standard
amounts
tive formulations resembling several commercial the slope of the IRIA titration and particularly
phenomenon
of PPV prepared
at the
in adjuvant/addi-
vaccines. All formulations decreased affected detection of higher levels of
PPV, indicating reduction in sensitivity. The formulation associated with the greatest depression in bound radioactivity at any given PPV level was one with a high level of
0
IO
20
30
40
50
60
70
80
HA UNITSOF PPV
Fig. 3. Titration in EMEM-5%
of PPV by IRIA in the presence of PBS (A---A), EMEM with 5% FBS (a--a), FBS (o---o),
or 5% CP gel in EMEM-5%
FBS (o-o).
10% AH gel
All points are means of duplicate
measurements. Fig. 4. Titrations is denoted triplicate
of PPV in the presence of 8 simulated
next to each titration. measurements.
All preparations
commercial
adjuvants.
made in EMEM-%%
Primary
adjuvant
FBS. All points
component are means
of
197
AH gel (up to 20% v/v). Experiments units
of PPV/lO
supernatants were essentially
measured.
negative
for PPV by IRIA, indicating
AH-based
preparation,
much PPV as the intact
measured
and
of both preparations
virus removal
substantially
by ultracentrifu-
lower in PPV than did
while the 2,000 X g CP supematant
CP preparation.
of 60 HA intact;
of the same preparations
The 85,000 X g supernatants
The 2,000 X g AH supernatant
the intact
in which preparations
of 2,000 X g and 85,000 X g centrifugations
were also concurrently gation.
were conducted
ul in 10% AH gel and in 5% CP gel were measured
These results indicated
contained
that a portion
as
of the
PPV in the AH formulation behaved as if it was associated with the AH particulate, and was removed with it by the low speed centrifugation, which easily pelleted AH but not CP. Commercial vaccines utilizing high levels of AH were also tested intact, and supernatants
of these vaccines centrifuged
well. It was found
2,000 X g supernatants parent products.
at 2,000 X g and 85,000 X g were analyzed
that 85,000 X g supernatants contained
substantially
The 2,000 X g supernatants
as much PPV as did the respective tants were again low in detectable
contained
minimal
less PPV than the intact
of AA and CP-based
intact products, PPV.
although
as
PPV, and that the AH-based
vaccines
contained
the 85,000 X g superna-
DISCUSSION
The IRIA demonstrated linearity over a practical range of PPV concentrations also detected very low and very high levels of PPV. The system recognized formalin-inactivated,
and BEI-inactivated
PPV equally
well, indicating
and live,
that the epi-
tope recognized by the MAB was not destroyed by the inactivants, at least for analytical purposes. When selecting a MAB for use in IRIA, one produced against an inactivated antigen might potentially measure a denatured epitope which is not antigenically protective. It would be desirable to use monoclonal antibodies which recognized only antigens which induced protective in vivo responses. The absolute specificity of monoclonal antibodies renders them highly useful when analyzing complex
fluids containing
cellular,
the basis of many conventionally
nutrient prepared
It was hypothesized that adjuvants many vaccines might noncompetitively tants and/or
enzymes
in enzyme-linked
serum, and viral proteins. cell-culture
origin
Such fluids form
vaccines.
and/or additives (e.g. thimerosal) present in inhibit, adsorb, or sterically hinder the reaccolorometric
assay systems which have been
used for measuring purified antigens (Furuya et al., 1984; Porter and Porter, 1984). These potential enzymatic complications might be expected to be lessened with a radioimmunological approach. IRIA is also exquisitely quantitative and unaffected by optical characteristics of nitrocellulose or material adsorbed to it. However, the radiological approach does involve a relatively unstable, expensive, and potentially hazardous immunoreagent. The cause of the significant decrease in bound radioactivity as a function of AH and CP concentration is enigmatic. There are at least three possible explanations of the
198
observed bound
decrease.
Firstly,
there may be some detachment
virus from the nitrocellulose
tendency
of nitrocellulose
particuiar,
during
to bind macromolecules,
the fine particulate
of adjuvant
the IRIA procedure.
AH adjuvant
its affinity
is unknown.
and adjuvant-
Despite
the general
for CP, AA, and, in
However,
results
of the
centrifugation experiments indicated that some or all of the AH was retained on the membrane, inasmuch as intact vaccines contained more measurable PPV than did the 2,000 X g supernatants
of the same vaccines,
which were essentially
ly, some virus may be loosely adjuvant-associated detach
into the liquid medium
during
Lastly, high levels of adjuvant noclonal
antibody
tive formulations
binding
affect IRIA sensitivity,
Second-
but not nitrocellulose-bound,
the IRIA even if adjuvant
may sterically
in the appropriate
AH-free.
itself remains
and bound.
hinder the MAB or the labelled anti-mosteps. Because specific adjuvant/addi-
as shown in Fig. 4, measurement
mass in a specific vaccine would require knowledge tion of that product.
of the adjuvant/additive
of antigenic composi-
Nevertheless, using homologous adjuvant/additive preparations containing known quantities of a reference antigen, it may be possible to assess some intact, adjuvanted, inactivated vaccines using IRIA to estimate antigenic mass. This would be one approach vaccines,
to rapid, practical, and economical in vitro potency testing of adjuvanted inactivated vaccines, or subunit vaccine products. The effects of specific
adjuvants
and additives
must be carefully
considered
for each vaccine in view of their
effects on IRIA sensitivity. ACKNOWLEDGEMENTS
We thank Mr. S.K. Hanson and Ms. I. Peterson for encouragement and excellent technical assistance, and Dr. R. Levings and Dr. W. Mengeling for encouragement and advice. REFERENCES
Flores, J., E. Boeggeman, Kapikian, Furuya,
K., S. Noro,
Hawkes,
Kostenbader,
T. Yamagishi
and N. Sakurada,
K.D. and D.O. Cliver, W.L., R.A. Whiteford,
Pig Vet. Sot. (Ghent, D.D. and H.G.
Southern,
E.M.,
Tsuchida.
N., S. Bhaduri,
Van Deusen. SD) p. 21 I.
A.Z.
I (8324) 555.
R., E. Niday and J. Gordon,
Mengeling, Porter,
R.M. Purcell, M. Serene, I. Perez, L. White, R.G. Wyatt, R.M. Chanockand
1983, Lancet
Belgium) Porter,
1984, Anal.
1984, J. Virol. Methods Biochem.
1983, J. Viral. Methods
9. 193.
119, 142. 7, 253.
R.A. Van Deusen, T.T. Kramer
and P.S. Paul, 1984, in: 8th Proc., Intl.
p. 15.
1984, J. Immunol.
Methods
72. 1.
1975, J. Mol. Biol. 98, 503. H.J. Heschel
R.A. and C.A. Whetstone.
and M. Green,
1973, Intervirology
I. 27.
19x1. in: 24th Ann. Proc.. Am. Assn. Vet. Lab. Diag. (Brookings.